Eli Lilly +2.8%
Why now
Thesis: Eli Lilly shares gain
Catalyst to watch: Drug trial or sales data
Main risk: Valuation leaves little room for misses
Why it matters
Pharma strength signals firm demand expectations for obesity and diabetes franchises.
Details
Eli Lilly (LLY) moved +2.8% in the latest period (1d). Close: 1183.53, prior: 1150.99.
Sources
- yfinance · finance.yahoo.com · 2026-09-24 00:00 UTC